smart inhaler

By Dave Muoio January 15, 2019
In light of its recent CE Mark, Kraków, Poland-based respiratory health company FindAir will begin sales of its digital inhaler add-on to European consumers tomorrow, the company announced in a press release. The FindAir One device wirelessly connects to an accompanying mobile and web app for patients and doctors alike. For the former, the app passively collects data with each use to monitor the...
By Dave Muoio December 31, 2018
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will first become available next year through a “small number” of healthcare system pilot partnerships, with a full national launch currently planned for 2020. Teva’s ProAir Digihaler is indicated for the...
By Babyforyou.net.ua August 13, 2018
Bankrupting docs? Patient booking platform Zocdoc is putting providers in a sticky situation, CNBC reports. The platform, which lets patients book and cancel appointments, is changing its business model. Now instead of charging providers a flat annual rate per doctor, it proposes to charge a lower annual rate as well as a booking fee for each new customer. Not only would this dramatically...
Adherium receives additional FDA clearance for OTC sale of inhaler sensors in the US

Credit: Adherium on

By Dave Muoio July 27, 2018
Connected inhaler sensor maker Adherium has received 510(k) clearance for US over-the-counter sales of its Hailie sensor, formerly known as Smartinhaler. Specifically, individual versions of the device have been cleared for use with the asthma inhalers ProAir HFA, Ventolin HFA, and Flovent HFA. “This latest clearance kicks off our official entry into the US consumer market, giving the tens of...
By Dave Muoio April 3, 2018
A partnership between Louisville, Kentucky city leaders, a non-profit, and digital respiratory health company Propeller Health has led to clear improvements in local asthmatic residents’ inhaler use and symptoms, according to a study recently published in Health Affairs.  Furthermore, data collected and made available through the digital respiratory health company’s crowdsourced platform offered...
By Dave Muoio April 2, 2018
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort. Adherium — which is headquartered in San Mateo, California, but holds currently offices in Melbourne, Australia; Auckland, New Zealand; and Amstelveen, The Netherlands...
By Dave Muoio February 13, 2018
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence. Following an unspecified investment in the...
By Jonah Comstock January 10, 2018
London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding. The amount was not disclosed. Sanner Ventures and Breed Reply (a previous investor) led the round. Amiko Digital Health’s flagship product, Respiro, consists of two parts. The first part is a connected inhaler for respiratory disease patients, which measures compliance, lung...
By Jonah Comstock April 6, 2017
Two Minneapolis-based companies – digital health care management program maker HealthFactors and medical-focused R&D firm Koronis BioMedical Technologies (KBT) – are working together to create new smart inhaler products for some undisclosed pharmaceutical partners, the company announced earlier this week. “Connected health technology, including smart inhalers, has the ability to improve...
By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...

Editor's Pick

здесь dopingman.com.ua

www.pills24.com.ua

www.bestseller.reviews